50 results on '"Bellopede, P"'
Search Results
2. Assessment of Environmental Parameters in Natural Coastal Scenery and Compositional by Means of an Innovative Approach
3. A literature-based database of the natural heritage, the ecological status and tourism-related impacts in show caves worldwide
4. Detection and Analysis of Microfibers and Microplastics in Wastewater from a Textile Company
5. Monkeypox Clinical Features and Differential Diagnosis: First Case in Campania Region
6. Study of Metal Recovery from Printed Circuit Boards by Physical-Mechanical Treatment Processes
7. Ornamental Stone Cutting Processing and Sludge Production Evaluation with the Goal of Ending Waste
8. Humanization of pediatric care in the world: focus and review of existing models and measurement tools
9. Characterization of natural stone material used in the Nordic eastern urban and costal environment
10. Performance-Related Assessment of the Potential Use of Sawing Sludge in Cementitious Fluidized Thermal Backfills
11. Occurrence of antibodies against Neospora caninum in wild pigs (Sus scrofa) in the Pantanal, Mato Grosso do Sul, Brazil
12. Assessment of the European Standard for the determination of resistance of marble to thermal and moisture cycles: recommendations for improvements
13. The Use of Tunnel Muck as Industrial Raw Material: Two Case-Studies
14. Optimisation of an abrasion resistance test method on natural stones
15. Release of microplastic fibers from synthetic textiles during household washing.
16. Elevated CD4+/CD25+ T cell frequency and function during acute hepatitis C presage chronic evolution
17. PREVALENCE OF HEPATIC IRON OVERLOAD (HIO) IN CHRONIC HEPATITIS C (CHC) AND B (CHB) AND ITS RELATIONSHIP TO LIVER INJURY AND RESPONSE TO IFN
18. Antiviral therapy in acute viral hepatitis B: why and when
19. Antiviral therapy in acute viral hepatitis B: why and when
20. C11/15 HCV GENOTYPE AND DEVELOPMENT OF HCC IN CIRRHOTIC PATIENTS
21. C01/171 ROLE OF HEPATIC IRON AND STEATOSIS ON EARLY RESPONSE TO INTERFERON (IFN) TREATMENT OF CHRONIC HEPATITIS C (CHC) PATIENTS (PTS)
22. COVID-19 among healthcare workers in a specialist infectious diseases setting in Naples, Southern Italy: results of a cross-sectional surveillance study.
23. Late HCC onset after direct antiviral agents therapy in patients with sustained virological response: do we need to reconsider their efficacy according to long term follow-up?
24. Safety of new DAAs for chronic HCV infection in a real life experience: role of a surveillance network based on clinician and hospital pharmacist
25. Marble Durability Assessment by Means of Total Optical Porosity and Adjacent Grain Analysis
26. Severe diarrhea occurring during alpha-interferon treatment for chronic hepatitis C is associated with serologic markers of celiac disease
27. Sequential analyses of HBV core promoter and precore regions in cancer survivor patients with chronic hepatitis B before, during and after interferon treatment
28. Coinfezione da HBV e HCV in pazienti oncologci di età pediatrica
29. Effects of long-term alfa interferon treatment in 344 patients with chronic hepatitis C: retrospective analysis of dosage and type of interferon used
30. HCV or mixed HCV-HBV infections acquired under therapy for neoplasia: long-term follow up and response to IFN
31. Progressione del danno epatico in pazienti con epatite cronica C: ruolo del genotipo virale e del livello della viremia
32. Epatocarcinoma e cirrosi epatica da HCV: significato del genotipo virale e dei livelli di HCV RNA nel siero
33. Long term effect of interferon (IFN) treatment of chronic hepatitis B (CHB) in pediatric patients cured of oncologic diseases
34. Role of HCV genotypes and HCV RNA levels in the hepatic damage of chronic hepatitis C patients
35. Long-term effect of interferon treatment of chronic hepatitis B in pediatric patients cured of oncologic disease
36. HCV genotypes and serum RNA levels in HCV-related cirrhosis with or without hepatocellular carcinoma (HCC)
37. HCV genotypes and serum RNA levels in HCV-related cirrhosis with and without hepatocellular carcinoma (HCC)
38. Thermal Stresses.
39. Prevalence of hepatic iron overload (HIO) in chronic hepatitis C (CHC)and B (CHB) and its relationship to liver injury and response to IFN
40. Microplastic pollution in show cave sediments: First evidence and detection technique.
41. Late HCC onset after DAAs therapy in patients with SVR: a type D ADR that requires a longer follow-up?
42. Dual or Single Hepatitis B and C Virus Infections in Childhood Cancer Survivors: Long-Term Follow-Up and Effect of Interferon Treatment
43. Antiviral therapy in acute viral hepatitis B: why and when [corrected] [published erratum appears in INFECT AGENTS CANCER 2009;4:1p].
44. Late HCC onset after DAAs therapy in patients with SVR: a type D ADR that requires a longer follow-up?
45. Impaired function of CD4CD25 T regulatory lymphocytes characterizes the self-limited hepatitis A virus infection
46. Dual or Single Hepatitis B and C Virus Infections in Childhood Cancer Survivors: Long-Term Follow-Up and Effect of Interferon Treatment
47. Elevated CD4+/CD25+ T cell frequency and function during acute hepatitis C presage chronic evolution
48. Late Hepatocellular Carcinoma Occurrence in Patients Achieving Sustained Virological Response After Direct-Acting Antiviral Therapy: A Matter of Follow-Up or Something Else?
49. Impaired function of CD4+/CD25+ T regulatory lymphocytes characterizes the self-limited hepatitis A virus infection.
50. Flow cytometry assay of myeloid dendritic cells (mDCs) in peripheral blood during acute hepatitis C: possible pathogenetic mechanisms.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.